Abu Dhabi's IHC, listed on Abu Dhabi Securities Exchange, has operations in the UAE, Middle East, Europe, and North America through its 12 subsidiaries. The company invests in a number of sectors such as real estate, manufacturing and financial services. (Oxford Nanopore has developed and commercializes a new generation of DNA/RNA sequencing technology. The palm-sized portable MinION device, and desktop GridION and PromethION devices. Most recently, Oxford Nanopore has developed the LamPORE COVID-19 test).
IHC is listed in the Middle East Investors Directory with the code MJ97.